ALZN (Alzamend Neuro) Liabilities-to-Assets : 0.25 (As of Oct. 2024)

Alzamend Neuro Liabilities-to-Assets Chart

Alzamend Neuro Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Liabilities-to-Assets	Get a 7-Day Free Trial															3.73	6.44	5.10	1.73	0.25

Competitive Comparison of Alzamend Neuro's Liabilities-to-Assets

For the Biotechnology subindustry, Alzamend Neuro's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alzamend Neuro's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzamend Neuro's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Alzamend Neuro's Liabilities-to-Assets falls into.

Alzamend Neuro Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Alzamend Neuro's Liabilities-to-Assets Ratio for the fiscal year that ended in Apr. 2024 is calculated as:

Alzamend Neuro's Liabilities-to-Assets Ratio for the quarter that ended in Oct. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzamend Neuro  (NAS:ALZN) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Alzamend Neuro Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Alzamend Neuro's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Alzamend Neuro Business Description